• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替考拉宁与万古霉素治疗耐甲氧西林金黄色葡萄球菌感染的比较:初步结果

Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.

作者信息

Van Laethem Y, Hermans P, De Wit S, Goosens H, Clumeck N

机构信息

Division of Infectious Diseases, Saint-Pierre University Hospital, Brussels, Belgium.

出版信息

J Antimicrob Chemother. 1988 Jan;21 Suppl A:81-7. doi: 10.1093/jac/21.suppl_a.81.

DOI:10.1093/jac/21.suppl_a.81
PMID:2965135
Abstract

Twenty-one patients were included in an open randomized study comparing vancomycin 1 g bd with teicoplanin 400 mg daily in severe methicillin-resistant Staphylococcus aureus infections. The median duration of therapy was 15 days for vancomycin and 21 days for teicoplanin. Most patients presented with severe underlying conditions, such as major surgery (8), solid tumours (5), multiple trauma (3). The infections treated, included septicaemia, osteomyelitis, bronchopneumonia, cellulitis and acute pyelonephritis. Mean MICs of the strains were 0.39 mg/l for vancomycin and 0.195 mg/l for teicoplanin. Mean trough and peak serum concentrations of vancomycin were 14.3 +/- 5 mg/l and 34.3 +/- 13 mg/l, while the teicoplanin values were 7.5 +/- 4 mg/l and 17 +/- 7 mg/l. The cure rate was seven of 12 in the teicoplanin group and six of nine in the vancomycin group, with four and three cases, respectively, of improvement and one failure in the teicoplanin group. Transient renal impairment occurred in two cases with both regimens; superinfection and colonization in three patients and one patient, respectively, with both regimens.

摘要

21例患者纳入一项开放性随机研究,该研究比较了在严重耐甲氧西林金黄色葡萄球菌感染中,每日两次静脉滴注1g万古霉素与每日静脉滴注400mg替考拉宁的疗效。万古霉素治疗的中位疗程为15天,替考拉宁为21天。大多数患者伴有严重的基础疾病,如大手术(8例)、实体瘤(5例)、多发伤(3例)。治疗的感染包括败血症、骨髓炎、支气管肺炎、蜂窝织炎和急性肾盂肾炎。菌株的平均最低抑菌浓度(MIC),万古霉素为0.39mg/L,替考拉宁为0.195mg/L。万古霉素的平均谷浓度和峰浓度分别为14.3±5mg/L和34.3±13mg/L,而替考拉宁的值分别为7.5±4mg/L和17±7mg/L。替考拉宁组12例中有7例治愈,万古霉素组9例中有6例治愈,替考拉宁组分别有4例和3例病情改善,1例治疗失败。两种治疗方案均有2例出现短暂性肾功能损害;两种治疗方案分别有3例和1例发生二重感染和定植。

相似文献

1
Teicoplanin compared with vancomycin in methicillin-resistant Staphylococcus aureus infections: preliminary results.替考拉宁与万古霉素治疗耐甲氧西林金黄色葡萄球菌感染的比较:初步结果
J Antimicrob Chemother. 1988 Jan;21 Suppl A:81-7. doi: 10.1093/jac/21.suppl_a.81.
2
Teicoplanin in infections caused by methicillin-resistant staphylococci.替考拉宁治疗耐甲氧西林葡萄球菌引起的感染。
J Antimicrob Chemother. 1988 Jan;21 Suppl A:89-92. doi: 10.1093/jac/21.suppl_a.89.
3
Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.耐甲氧西林金黄色葡萄球菌所致感染性心内膜炎的治疗:一项回顾性研究中替考拉宁与万古霉素的对比
Scand J Infect Dis. 2008;40(6-7):462-7. doi: 10.1080/00365540701837126.
4
Activity of teicoplanin in localized experimental infections in rats.替考拉宁在大鼠局部实验性感染中的活性。
J Hosp Infect. 1986 Mar;7 Suppl A:91-9. doi: 10.1016/0195-6701(86)90013-7.
5
Teicoplanin, vancomycin, rifampicin: in-vivo and in-vitro studies with Staphylococcus aureus.替考拉宁、万古霉素、利福平:针对金黄色葡萄球菌的体内和体外研究。
J Antimicrob Chemother. 1987 May;19(5):659-62. doi: 10.1093/jac/19.5.659.
6
Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.糖肽类药物在兔心内膜炎模型中对金黄色葡萄球菌感染的活性:最低抑菌浓度不能预测体内疗效。
Antimicrob Agents Chemother. 2005 Feb;49(2):857-9. doi: 10.1128/AAC.49.2.857-859.2005.
7
Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.替考拉宁与萘夫西林及万古霉素治疗由甲氧西林敏感或耐药金黄色葡萄球菌引起的实验性心内膜炎的比较。
Antimicrob Agents Chemother. 1984 Jul;26(1):61-4. doi: 10.1128/AAC.26.1.61.
8
Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.金黄色葡萄球菌血管内感染患者每天使用6毫克/千克替考拉宁治疗失败。俄勒冈传染病联盟。
Antimicrob Agents Chemother. 1991 Jan;35(1):79-87. doi: 10.1128/AAC.35.1.79.
9
Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycin.两名中性粒细胞减少且患有葡萄球菌败血症的患者接受替考拉宁治疗失败,给予万古霉素后康复。
Eur J Clin Microbiol Infect Dis. 1990 Feb;9(2):145-7. doi: 10.1007/BF01963643.
10
Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.替考拉宁与万古霉素对金黄色葡萄球菌临床分离株的体外活性比较。
J Chemother. 2012 Aug;24(4):187-90. doi: 10.1179/1973947812Y.0000000026.

引用本文的文献

1
Efficacy and Safety of Antibiotics in the Treatment of Methicillin-Resistant (MRSA) Infections: A Systematic Review and Network Meta-Analysis.抗生素治疗耐甲氧西林金黄色葡萄球菌(MRSA)感染的疗效与安全性:一项系统评价与网状Meta分析
Antibiotics (Basel). 2024 Sep 10;13(9):866. doi: 10.3390/antibiotics13090866.
2
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in surgical wounds.用于治疗手术伤口耐甲氧西林金黄色葡萄球菌(MRSA)感染的抗生素疗法。
Cochrane Database Syst Rev. 2013 Aug 20;2013(8):CD009726. doi: 10.1002/14651858.CD009726.pub2.
3
Meta-analysis of randomized controlled trials of vancomycin for the treatment of patients with gram-positive infections: focus on the study design.
万古霉素治疗革兰阳性感染患者的随机对照试验的荟萃分析:重点关注研究设计。
Mayo Clin Proc. 2012 Apr;87(4):349-63. doi: 10.1016/j.mayocp.2011.12.011.
4
Decal bone matrix as a local antibiotic delivery vehicle in a MRSA-infected bone model: An experimental study.脱钙骨基质作为耐甲氧西林金黄色葡萄球菌感染骨模型中的局部抗生素递送载体:一项实验研究。
Indian J Orthop. 2010 Jul;44(3):246-51. doi: 10.4103/0019-5413.65140.
5
Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis.万古霉素与替考拉宁的疗效和安全性比较:系统评价与荟萃分析
Antimicrob Agents Chemother. 2009 Oct;53(10):4069-79. doi: 10.1128/AAC.00341-09. Epub 2009 Jul 13.
6
The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.耐甲氧西林金黄色葡萄球菌感染与定植的管理:一份加拿大感染病学会/加拿大抗菌药物管理协会立场文件
Can J Infect Dis. 2004 Jan;15(1):39-48. doi: 10.1155/2004/531434.
7
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.单独使用替考拉宁或联合利福平与万古霉素相比,用于预防和治疗耐甲氧西林金黄色葡萄球菌引起的实验性异物感染。
Antimicrob Agents Chemother. 1994 Aug;38(8):1703-10. doi: 10.1128/AAC.38.8.1703.
8
Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients.替考拉宁:一种耐受性良好且易于给药的万古霉素替代药物,用于重症监护患者的革兰氏阳性菌感染。
Intensive Care Med. 1994 Nov;20 Suppl 4:S35-42. doi: 10.1007/BF01713981.
9
Anti-infective treatment in intensive care: the role of glycopeptides.重症监护中的抗感染治疗:糖肽类药物的作用
Intensive Care Med. 1994 Nov;20 Suppl 4:S17-22. doi: 10.1007/BF01713978.
10
Teicoplanin pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis after intravenous and intraperitoneal dosing.静脉注射和腹腔内给药后持续非卧床腹膜透析患者的替考拉宁药代动力学
Antimicrob Agents Chemother. 1989 Nov;33(11):2012-5. doi: 10.1128/AAC.33.11.2012.